Surge in VC funding, dealmaking will improve biotech drug pipeline

06/20/2014 | Genetic Engineering & Biotechnology News

The recent uptick in venture capital investments in the biotechnology sector and the increasing number of partnerships between large and smaller biotech firms should help drugmakers replenish their pipeline and come up with better products in the future. Data from a Moneytree report showed that the biotech industry secured more than $4 billion in venture capital investments last year, an 8% growth, making it the second-biggest investment sector for venture capitalists for the year.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA